Company to create new biomanufacturing jobs in Rhode Island

Posted on May 3, 2018

One company is growing and will create more biomanufacturing jobs in Rhode Island.

Amgen, a biotechnology company, will expand in Rhode Island, with a new $160-million next-generation biomanufacturing plant that will be the first of its kind in the United States.

The facility, which will produce approximately 150 new highly-skilled manufacturing jobs, will be supported by incentives from Rhode Island’s innovative toolkit of economic development programs.

“I am thrilled that Amgen is planning to expand and bring new, highly skilled jobs to Rhode Island and further enhance the State’s life sciences community and manufacturing expertise,” said Governor Gina M. Raimondo. “We welcome Amgen’s future health care advancements for patients around the world that will come from this new biomanufacturing plant.”

Amgen’s new biomanufacturing plant will be built on the current Amgen Rhode Island 75-acre campus in West Greenwich and is expected to create approximately 150 additional highly-skilled manufacturing positions with the potential for up to 300 in the coming years. In addition, the project will create hundreds of construction and validation jobs.

The new plant will employ Amgen’s proven next-generation biomanufacturing capabilities and manufacture products for the U.S. and global markets. Amgen currently employs 625 full-time employees in Rhode Island.

“We are excited that Amgen Rhode Island was chosen as the location to build the new biomanufacturing plant,” said Tia Bush, vice president of Operations at Amgen Rhode Island. “It is a testament to our skilled, dedicated workforce and Amgen’s continued presence in Rhode Island, which will enable ongoing collaborations with local academic institutions and the broader Rhode Island community.”